About Nozin

The Company

Global Life Technologies Corp. (GLT) is the maker of Nozin® brand products including Nozin® Nasal Sanitizer® antiseptic and Nozin® Allergy Master® products. Located in Bethesda, MD, this U.S. based company follows a mission to improve the quality of life for people by enhancing healthcare with new products based on innovative patented and patent pending technologies.  These technologies are supported by substantial research, development and successful clinical trials (see information below and FAQ pages). Nozin® Nasal Sanitizer® antiseptic is used by healthcare facilities for infection control and presents a new option to safely reduce nasal carriage without antibiotics while lowering infection control costs. Our Company motto is to "enhance life through innovative health technologies".

Backed by years of research and development, supported by NIH grants and successful clinical trials, Nozin products are directed at growing health maintenance and infection prevention markets. Made in the USA, Nozin products have been well received by doctors and healthcare professionals who use them and recommend them to patients. The Company intends to fulfill its mission through the development, marketing and sales of superior healthcare products throughout the world.

Meet the GLT Leadership Team


Scientific Steering Committee and Advisory Board

We are committed to continuing our investments in research and have enlisted the support of the scientific community by forming a Scientific Steering Committee composed of prominent scientists from major research universities in the United States. The scientists on this committee are all independently funded by the National Institutes of Health to carry out research in areas related to transmission of infectious diseases. The Steering Committee has, in turn, identified and recruited independent scientists who are recognized as the leading experts in the area of airborne diseases to carry out the studies that validate the efficacy of Nozin. Validation and support from renowned physicians and researchers is central to our aim of providing quality health products to consumers.

Dr. Richard Markham, the Chairman of GLT's Scientific Steering Committee, a Medical Doctor and renowned infectious disease specialist, is known for his groundbreaking work in the area of novel microbicides, an area that GLT is actively pursuing.

Experts such as Dr. Markham, and others, are actively contributing to the scientific direction of the Company.

The Steering Committee looks at prevention

By Dr. Richard Markham, Committee Chairman

Dr. Richard MarkhamThe members of the Scientific Steering Committee are academic scientists and physicians who are committed to the field of Public Health. This means that much of their research has focused on the issue of disease prevention, as opposed to disease treatment. Disease prevention is an area that, in the past, has received less attention from the medical community. Most physicians, after all, are trained to treat patients who come to them with an illness. But as the costs of medical treatment continue to climb it has become clear that simpler approaches, which make disease prevention accessible to all individuals, must be developed.

One approach that has proved useful is the development of antiseptics such as alcohol-based hand sanitizers to help reduce the risk of infection by decreasing potential exposure to pathogens. But for many infections the hands serve only as the vehicle that carries germs to the site where infection is actually initiated and introduced into the body, such as the eyes, mouth and especially the nose. It is this concept of attacking infections at the site where the acquisition process actually begins that attracted the scientists who are members or advisors of the GLT Scientific Steering Committee. It is the scientists' goal to use rigorous scientific analysis to ensure that products such as Nozin® Nasal Sanitizer® antiseptic are the most effective they can possibly be.

Nozin® Nasal Sanitizer®


Nozin Nasal Sanitizer®: Defense that makes sense®

Nozin® Nasal Sanitizer® antiseptic is an innovative, patented product that benefits consumers, health professionals and their patients by providing extra protection against germs. In the past decade, hand sanitizers have become recognized and popularly used to deter transmission of germs. Because hand-to-nose contact is an important mechanism for the transmission of infection, it can be beneficial to promote hygiene on the nasal vestibule skin as well as on the hands.

Nozin Nasal Sanitizer® antiseptic is specially formulated for the vulnerable and sensitive skin at the distal area of the nose (nasal vestibule) and helps control germ populations that come to reside there. Lab tests show that Nozin Nasal Sanitizer® antiseptic kills harmful germs. Human trial results show that one application of Nozin Nasal Sanitizer® antiseptic can be effective (see above test summaries and results).

Unlike many existing products that purport to offer protection, Nozin® Nasal Sanitizer® antiseptic is unique in that it attacks germs at the nasal vestibule which is a known reservoir for microbial colonization. The Center for Disease Control already heavily promotes the importance of frequent hand washing and of hand sanitizers in helping prevent germs residing on hands from being Nozin® Nasal Sanitizer®transmitted to the nose. Nozin® Nasal Sanitizer® antiseptic directly targets the skin at the front of the nose, the nasal vestibule, a critical site of germ transmission.  Nozin Nasal Sanitizer antiseptic adds a targeted level of defense by helping to shield your nose. Regular use of Nozin Nasal Sanitizer antiseptic in conjunction with hand washing could provide a very effective hygienic regimen which can help reduce the risk of infection.

Many top physicians and scientists realize the compelling logic of hygienic innovation that Nozin offers. Nozin Nasal Sanitizer antiseptic is a professionally valued and sensible approach in the effort to reduce the risk of infection.

Significance of Nozin

Studies indicate that the active ingredient in Nozin® Nasal Sanitizer® antiseptic is safe and has substantial activity against a broad spectrum of pathogenic organisms. The research also shows that the Nasal Sanitizer® Nozaseptin® formulation has activity that persists for hours after application.

In light of the ubiquitous occurrence and medically important consequences of infections, and the evidence that a topical antiseptic can be beneficial, this simple and safe intervention could be an effective aid in the reduction of infections.

Conclusion: Benefits of using Nozin Nasal Sanitizer®

Many of us are aware that every time we are in a crowded plane, bus, train, or in other settings such as hospitals, we may be more likely to be exposed pathogens.

Better health and enhanced lifestyle can be key benefits of adopting a sound hygienic routine. Consumers who adopt and commit to a low-cost and effective hygienic regimen  know they are doing something to help ensure their health and improve their quality of life.

Top physicians and scientists realize that the hygienic benefits Nozin® Nasal Sanitizer® antiseptic offers could provide critical first line defense in high risk, crowded or confined areas (e.g. airplanes, offices, athletic facilities, schools, theaters, hospitals, nursing homes, etc). Nozin® Nasal Sanitizer® antiseptic can help reduce the risk of infection as an important part of health maintenance and in the fight against germ transmission.

[Back to top]

Health Professionals:
Request a comprehensive analysis of your colonization risk mitigation protocols today.

© 2004-2024 Global Life Technologies Corp. All rights reserved. All trademarks are property of their respective owners. Nozin® Nasal Sanitizer® antiseptic is an OTC topical antiseptic drug and no claim is made that it has an effect on any specific disease. | Patent Nos.